Philip M. Arlen
Chief Executive Officer at Precision Biologics, Inc.
Philip M. Arlen active positions
Companies | Position | Start | End |
---|---|---|---|
Precision Biologics, Inc.
Precision Biologics, Inc. Drugstore ChainsRetail Trade Precision Biologics, Inc. develops therapeutic and diagnostic products for the early detection and treatment of cancer. Its antibody drug candidates and diagnostics are designed to detect and target the tumor without destroying healthy cells. The company was founded in February 2012 and is headquartered in Dallas, TX. | Director/Board Member | - | - |
Chief Executive Officer | 31/08/2012 | - | |
President | 31/08/2012 | - |
Career history of Philip M. Arlen
Former positions of Philip M. Arlen
Companies | Position | Start | End |
---|---|---|---|
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | 31/12/2007 | - |
Walter Reed National Military Medical Center | Corporate Officer/Principal | - | - |
Neogenix Oncology, Inc.
Neogenix Oncology, Inc. Medical SpecialtiesHealth Technology Founded in December 2003, Neogenix Oncology is a clinical stage biotechnology company focused on developing therapeutic and diagnostic products for the early detection and treatment of cancer. The company's antibody drug candidates and diagnostics are designed to detect and target the tumor without destroying healthy cells. Neogenix Oncology is uniquely positioned to create innovative therapeutics through the use of proprietary cancer vaccines, several of which have demonstrated success in human trials. By marrying this platform with today's breakthrough technologies, the company is developing antibody therapeutics that could change the way it detects and treats cancer. | Director/Board Member | 02/05/2011 | - |
Chief Executive Officer | 30/06/2008 | - | |
Chief Tech/Sci/R&D Officer | 30/06/2008 | - | |
President | 30/06/2008 | - |
Training of Philip M. Arlen
Emory University | Undergraduate Degree |
Georgia Health Sciences University | Doctorate Degree |
Statistics
International
United States | 7 |
Operational
Director/Board Member | 2 |
Chief Executive Officer | 2 |
President | 2 |
Sectoral
Consumer Services | 3 |
Health Technology | 2 |
Miscellaneous | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 4 |
---|---|
Neogenix Oncology, Inc.
Neogenix Oncology, Inc. Medical SpecialtiesHealth Technology Founded in December 2003, Neogenix Oncology is a clinical stage biotechnology company focused on developing therapeutic and diagnostic products for the early detection and treatment of cancer. The company's antibody drug candidates and diagnostics are designed to detect and target the tumor without destroying healthy cells. Neogenix Oncology is uniquely positioned to create innovative therapeutics through the use of proprietary cancer vaccines, several of which have demonstrated success in human trials. By marrying this platform with today's breakthrough technologies, the company is developing antibody therapeutics that could change the way it detects and treats cancer. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
Walter Reed National Military Medical Center | |
Precision Biologics, Inc.
Precision Biologics, Inc. Drugstore ChainsRetail Trade Precision Biologics, Inc. develops therapeutic and diagnostic products for the early detection and treatment of cancer. Its antibody drug candidates and diagnostics are designed to detect and target the tumor without destroying healthy cells. The company was founded in February 2012 and is headquartered in Dallas, TX. | Retail Trade |
- Stock Market
- Insiders
- Philip M. Arlen
- Experience